CN Stock MarketDetailed Quotes

600993 Mayinglong Pharmaceutical Group

Watchlist
  • 27.75
  • -0.06-0.22%
Market Closed Jun 3 15:00 CST
11.96BMarket Cap26.38P/E (TTM)

Mayinglong Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mayinglong Pharmaceutical Group Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

955.02M

+14.70%
EPS(YoY)

0.46

+4.55%
Analyst Rating

Strong Buy

Jun 3, 2024

Mayinglong Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20192019/Q1609.963M / 587.679M--
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20192019/Q1609.963M / 587.679M--

Mayinglong Pharmaceutical Group Earnings Reports

  • Ma Yinglong's 2024 First Quarter Report

    Apr 19 11:00

  • Ma Yinglong\'s 2023 Annual Report Summary

    Apr 12 11:00

  • Ma Yinglong's 2023 Annual Report

    Apr 12 11:00

  • Ma Yinglong\'s Report for the Third Quarter of 2023

    Oct 27, 2023 11:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 3, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg